Monte Rosa Therapeutics Inc (GLUE) — Cash Flow Quality Index

Latest as of March 2025: -0.97x

Monte Rosa Therapeutics Inc (GLUE) has a Cash Flow Quality Index of -0.97x as of March 2025. Operating cash flow of $-45.49 Million is below net income of $46.88 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore GLUE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.97x

Operating CF / Net Income

Operating Cash Flow

$-45.49 Million

USD

Net Income

$46.88 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Monte Rosa Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Monte Rosa Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.